Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(188)
•••
Comment by Sonny7on May 28, 2016 2:19am
117 Views
Post# 24912572

RE:RE:RE:RE:RE:RE:RE:RE:RE:selling

RE:RE:RE:RE:RE:RE:RE:RE:RE:sellingSmitty, please get a grip. Yes,......, I think it would be heard to break .40 with no material news!!! Can't you just be thankful that the stock is showing some strength? You claim to be in for so long and yet it shows that you don't know what you have, but yet, really, all you have is what everyone else has; a position in SVA. How did you get here? And why do you appeal to this board for your "due diligence"? This company doesn't distribute useless "fluff" and they are professionals doing what I think is a good job behind the scenes for the company and have lots on the go with the different levels of the company business. I have patience. 

But, in answer to your question, Yes, news is coming out, whenever it's ready. Let's hope it's not bad news. What do you think?
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities